Xuxu Gou

10PUBLICATIONS
99CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomolecular modelling and designCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 12, 2026
ESR1 fusions in breast cancer: functions, mechanisms and therapeutic opportunities.

|Jul 15, 2026
LIG1 Loss in TP53-mutant Triple Negative Breast Cancer Rewires DNA Repair and Confers Sensitivity to PARP-ATR Inhibitor Combinations.

|Nov 26, 2025
Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells.

Xuxu Gou, Huadong Chen, Morgan E Diolaiti

|Sep 24, 2024
PARP7 Inhibitors and AHR Agonists Act Synergistically across a Wide Range of Cancer Models.

Huadong Chen, Xuxu Gou, Ying Mao

|May 23, 2024
PKMYT1 Is a Marker of Treatment Response and a Therapeutic Target for CDK4/6 Inhibitor-Resistance in ER+ Breast Cancer.

Anran Chen, Beom-Jun Kim, Aparna Mitra

|Apr 04, 2024
De novo design of drug-binding proteins with predictable binding energy and specificity.

Lei Lu, Xuxu Gou, Sophia K Tan

Pageof 2

Frequent Collaborators

6 joint publications

Matthew J Ellis

5 joint publications

Jonathan T Lei

4 joint publications

Lacey E Dobrolecki

4 joint publications

Charles E Foulds